Gene Therapy Advances in Diabetes, Vision, Cancer & More
Автор: LucidQuest
Загружено: 2025-07-18
Просмотров: 11
Описание: This week in gene and cell therapy: Amarna and NorthX advance a type 1 diabetes gene therapy toward 2027 trials, while Bio-Techne’s platform supports ZEVASKYN’s FDA approval for RDEB. Biocad targets 2026 for Russia’s first hemophilia gene therapy, and Nanoscope begins FDA submission for gene-agnostic vision therapy. Sanofi gains Fast Track for macular degeneration, MiNK achieves remission in metastatic cancer, and FDA rejections hit Capricor and Ultragenyx. JCR licenses its AAV platform to AstraZeneca in a deal worth up to $825 million.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: